Apalutamide will reduce the extent or outcome of ethinylestradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of apalutamide, a powerful CYP3A4 inducer, with drugs which might be CYP3A4 substrates can lead to lessen publicity to these drugs. WEBWYMZYA Fe may be initiated no previously than https://wymzyafe96282.livebloggs.com/36491012/a-review-of-wymzya-fe-reviews